Literature DB >> 6155435

Interferon induction by viruses. IV. Sindbis virus: early passage defective-interfering particles induce interferon.

F J Fuller, P I Marcus.   

Abstract

We have shown that a single defective-interfering (DI) particle of early (5th) passage Sindbis virus induces maximal amounts of interferon in an 'aged' primary chick embryo cell. The capacity of such DI particles to induce interferon is inactivated by small amounts of u.v. radiation (i/e dose = 232 ergs/mm2). The I/e dose for inactivation of the interferon-inducing capacity of infectious virus particles is 399 ergs/mm2 and for infectivity is 101 ergs/mm2. Pre-treatment with interferon blocks formation of interferon in response to either DI or infectious virus particles. Our results suggest that Sindbis virus genes must be expressed to form the interferon inducer, which is presumably a molecule of double-stranded (ds)RNA. We postulate that for interferon induction, the genomic RNA which codes for genes G and A must be translated into products whose concerted action produces a dsRNA molecule upon synthesis of a segment of RNA complementary to the genome. The RNA from early passage DI particles is sufficiently large (25S, 1.6 x 10(6) mol. wt.) to accommodate these genes, whereas the RNA from the late passage DI particles (20S, 1.0 x 10(6) mol. wt.) is not. Late (15th) passage DI particles do not induce interferon formation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155435     DOI: 10.1099/0022-1317-48-1-63

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

Review 1.  Defective viral genomes: critical danger signals of viral infections.

Authors:  Carolina B López
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

Review 2.  What Really Rigs Up RIG-I?

Authors:  Sailen Barik
Journal:  J Innate Immun       Date:  2016-07-21       Impact factor: 7.349

Review 3.  The interferon renaissance: molecular aspects of induction and action.

Authors:  J Gordon; M A Minks
Journal:  Microbiol Rev       Date:  1981-06

4.  Analysis of intrahost variation in Venezuelan equine encephalitis virus reveals repeated deletions in the 6-kilodalton protein gene.

Authors:  N L Forrester; M Guerbois; A P Adams; X Liang; S C Weaver
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

5.  Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses.

Authors:  Reed S Shabman; Thomas E Morrison; Christopher Moore; Laura White; Mehul S Suthar; Linda Hueston; Nestor Rulli; Brett Lidbury; Jenny P-Y Ting; Suresh Mahalingam; Mark T Heise
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

6.  Failure to activate the IFN-β promoter by a paramyxovirus lacking an interferon antagonist.

Authors:  M J Killip; D F Young; C S Ross; S Chen; S Goodbourn; R E Randall
Journal:  Virology       Date:  2011-04-22       Impact factor: 3.616

Review 7.  Defective viral genomes are key drivers of the virus-host interaction.

Authors:  Marco Vignuzzi; Carolina B López
Journal:  Nat Microbiol       Date:  2019-06-03       Impact factor: 17.745

8.  Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes.

Authors:  Laura I Levi; Veronica V Rezelj; Annabelle Henrion-Lacritick; Diana Erazo; J Boussier; Thomas Vallet; Veronika Bernhauerová; Yasutsugu Suzuki; Lucia Carrau; James Weger-Lucarelli; Maria-Carla Saleh; Marco Vignuzzi
Journal:  PLoS Pathog       Date:  2021-02-08       Impact factor: 6.823

9.  Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation.

Authors:  Dylan M Johnson; Beatrice Cubitt; Tia L Pfeffer; Juan Carlos de la Torre; Igor S Lukashevich
Journal:  Viruses       Date:  2021-01-30       Impact factor: 5.048

Review 10.  Defective (interfering) viral genomes re-explored: impact on antiviral immunity and virus persistence.

Authors:  Tomaz B Manzoni; Carolina B López
Journal:  Future Virol       Date:  2018-06-12       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.